Ani Pharmaceuticals (ANIP) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Ani Pharmaceuticals (ANIP) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -11.41% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 8.48% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 27.10% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -7.49% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.12% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 11.74% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -11.76% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 7.32% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Ani Pharmaceuticals | 1.71 Bn | 1.40 Bn | 143.88 Mn | 15.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75% |
| Dec 31, 2025 | 13.05% |
| Sep 30, 2025 | 14.06% |
| Jun 30, 2025 | 10.62% |
| Mar 31, 2025 | 3.34% |
| Dec 31, 2024 | 2.59% |
| Sep 30, 2024 | 12.78% |
| Jun 30, 2024 | 8.59% |
| Mar 31, 2024 | 5.98% |
| Dec 31, 2023 | 2.62% |
| Sep 30, 2023 | 3.00% |
| Jun 30, 2023 | 3.57% |
| Mar 31, 2023 | 2.36% |
| Dec 31, 2022 | 2.17% |
| Sep 30, 2022 | 2.52% |
| Jun 30, 2022 | 3.96% |
| Mar 31, 2022 | 11.11% |
| Dec 31, 2021 | 11.41% |
| Sep 30, 2021 | 1.84% |
| Jun 30, 2021 | 20.87% |